Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FW1EN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,337
Award facts
- Contract value 100% obligated
- $62,336.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $62,336.92 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on May 27, 2025, with completion scheduled for May 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat various autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, reflecting the Defense Health Agency's need for specialty pharmaceutical products to support military healthcare programs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, regularly fulfills federal medical procurement requirements through open competition, demonstrating its capability to meet specialized and high-value medical supply needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FW1EN?
SPE2DB25FW1EN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FW1EN worth?
The government has obligated $62,337 on SPE2DB25FW1EN.
Is contract SPE2DB25FW1EN an order under another contract?
Yes. SPE2DB25FW1EN is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB25FW1EN competed?
The extent of competition for SPE2DB25FW1EN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award